219 results
424B2
AMNA
Ubs Ag
22 Apr 24
Prospectus for primary offering
6:35pm
that are engaged in the research and development of therapeutic treatments (but that are not focused on the commercialization and mass production
424B2
AMNA
Ubs Ag
17 Apr 24
Prospectus for primary offering
3:24pm
includes large-, mid- and small-capitalization companies that are engaged in the research and development of therapeutic treatments
424B2
AMNA
Ubs Ag
16 Apr 24
Prospectus for primary offering
3:14pm
in the health care sector require significant research and development and may be subject to regulatory approvals, all of which may be time consuming
424B2
AMNA
Ubs Ag
12 Apr 24
Prospectus for primary offering
11:07am
in technologies or other market developments. Many new products in the health care sector require significant research and development and may be subject
424B2
AMNA
Ubs Ag
9 Apr 24
Prospectus for primary offering
12:21pm
or other market developments. Many new products in the health care sector require significant research and development and may be subject
424B2
njbo5xwsj748uf77vl
5 Apr 24
Prospectus for primary offering
5:26pm
424B2
jl0d2f5b2bh
28 Mar 24
Prospectus for primary offering
1:40pm
6-K
d5xajquciw8h799e
28 Mar 24
Current report (foreign)
6:44am
424B2
p1hsq q2ecj642pa
22 Mar 24
Prospectus for primary offering
11:36am
424B2
zxef9z5qsdlcvdt3gx
29 Feb 24
Prospectus for primary offering
12:04pm
424B2
pc553ng50 0hs5
26 Feb 24
Prospectus for primary offering
1:24pm
424B2
fj58 9rl4
22 Jan 24
Prospectus for primary offering
10:35am
424B3
7a4 pa5tb2hsg
18 Jan 24
Prospectus supplement
10:11am
424B2
8ntfgubxw39ti858
11 Jan 24
Prospectus for primary offering
10:47am
424B2
v898xn1l
29 Dec 23
Prospectus for primary offering
3:47pm
424B2
6v3sogje
20 Dec 23
Prospectus for primary offering
1:45pm
424B2
rwrp6hsz l5rkqwso5
2 Aug 23
Prospectus for primary offering
4:30pm
424B2
4rwz wnxv
2 Aug 23
Prospectus for primary offering
4:13pm
424B2
ndzrl 89m
28 Jul 23
Prospectus for primary offering
12:37pm